Table 2.

LRG-1 serum levels in breast cancer patients. Values of LRG-1 are given in µg/ml and represent mean ± standard deviation. Comparison of two groups was assessed using the non-parametric, two‐sided Mann–Whitney test. Groups of three were assessed by ANOVA

	LRG-1 (µg/ml)	p value
Age (years)
< 60  > 60	28.85 ± 8.63 30.49 ± 8.63	0.011
Menopausal status
Premenopausal	26.93 ± 6.94
Perimenopausal	30.21 ± 11.36
Postmenopausal	30.15 ± 8.34	(0.002 vs pre.)
Histology
Ductal	29.84 ± 8.85	ns
Lobular	27.99 ± 7.74
Others	30.80 ± 8.23
Tumor stage
pT1	29.37 ± 8.09	ns
pT2	29.85 ± 9.62
pT3–4	32.68 ± 8.95
Nodal status
Node negative	29.36 ± 8.70	ns
Node positive	30.02 ± 8.47
Grading
I	30.89 ± 7.98	ns
II	29.37 ± 8.18
III	29.51 ± 9.75
ER status
Negative	28.97 ± 10.52	ns
Positive	29.89 ± 8.17
PR status
Negative	29.17 ± 8.86	ns
Positive	29.92 ± 8.58
Her2 status
Negative	29.87 ± 8.61	ns
Positive	28.66 ± 8.78
DTC status
Negative	30.51 ± 8.69	0.004
Positive	28.51 ± 8.54

ns not significant